Predictive Maintenance on the Machining Process and Machine Tool

This paper presents the process required to implement a data driven Predictive Maintenance (PdM) not only in the machine decision making, but also in data acquisition and processing. A short review of the different approaches and techniques in maintenance is given. The main contribution of this paper is a solution for the predictive maintenance problem in a real machining process. Several steps are needed to reach the solution, which are carefully explained. The obtained results show that the Preventive Maintenance (PM), which was carried out in a real machining process, could be changed into a PdM approach. A decision making application was developed to provide a visual analysis of the Remaining Useful Life (RUL) of the machining tool. This work is a proof of concept of the methodology presented in one process, but replicable for most of the process for serial productions of pieces

Theranostic liposome–nanoparticle hybrids for drug delivery and bioimaging

Advanced theranostic nanomedicine is a multifunctional approach which combines the diagnosis and effective therapy of diseased tissues. Here, we investigated the preparation, characterization and in vitro evaluation of theranostic liposomes. As is known, liposome–quantum dot (L–QD) hybrid vesicles are promising nanoconstructs for cell imaging and liposomal-topotecan (L-TPT) enhances the efficiency of TPT by providing protection against systemic clearance and allowing extended time for it to accumulate in tumors. In the present study, hydrophobic CdSe/ZnS QD and TPT were located in the bilayer membrane and inner core of liposomes, respectively. Dynamic light scattering (DLS), zeta potential (ζ) measurements and fluorescence/absorption spectroscopy were performed to determine the vesicle size, charge and spectroscopic properties of the liposomes. Moreover, drug release was studied under neutral and acidic pH conditions. Fluorescence microscopy and flow cytometry analysis were used to examine the cellular uptake and intracellular distribution of the TPT-loaded L–QD formulation. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was utilized to investigate the in vitro cytotoxicity of the formulations on HeLa cells. According to the results, the TPT-loaded L–QD hybrid has adequate physicochemical properties and is a promising multifunctional delivery vehicle which is capable of a simultaneous co-delivery of therapeutic and diagnostic agents.Konrad Adenauer Foundatio

Synthesis of size-tunable polymeric nanoparticles enabled by 3D hydrodynamic flow focusing in single-layer microchannels

Author Manuscript date: 2011 June 27A versatile microfluidic platform to synthesize NPs by nanoprecipitation using 3D hydrodynamic flow focusing isolates the precipitating precursors from channel walls, eliminating fouling of the channels. It is shown that this new method enables robust nanoprecipitation without polymer aggregation, regardless of the polymer molecular weight or precursor concentration implemented, where the size of the resulting polymeric NPs is tunable.David H. Koch (Prostate Cancer Foundation Award in Nanotherapeutics)National Institutes of Health (U.S.) (Grant CA119349)National Science Foundation (U.S.) (Graduate Research Fellowship

Microfluidic technologies for accelerating the clinical translation of nanoparticles

Using nanoparticles for therapy and imaging holds tremendous promise for the treatment of major diseases such as cancer. However, their translation into the clinic has been slow because it remains difficult to produce nanoparticles that are consistent 'batch-to-batch', and in sufficient quantities for clinical research. Moreover, platforms for rapid screening of nanoparticles are still lacking. Recent microfluidic technologies can tackle some of these issues, and offer a way to accelerate the clinical translation of nanoparticles. In this Progress Article, we highlight the advances in microfluidic systems that can synthesize libraries of nanoparticles in a well-controlled, reproducible and high-throughput manner. We also discuss the use of microfluidics for rapidly evaluating nanoparticles in vitro under microenvironments that mimic the in vivo conditions. Furthermore, we highlight some systems that can manipulate small organisms, which could be used for evaluating the in vivo toxicity of nanoparticles or for drug screening. We conclude with a critical assessment of the near- and long-term impact of microfluidics in the field of nanomedicine.Prostate Cancer Foundation (Award in Nanotherapeutics)MIT-Harvard Center for Cancer Nanotechnology Excellence (U54-CA151884)National Heart, Lung, and Blood Institute (Programs of Excellence in Nanotechnology (HHSN268201000045C))National Science Foundation (U.S.) (Graduate Research Fellowship

Quantitative evaluation of predominant of weeds in winter wheat and barley fields in Eastern Azerbaijan, Iran | Evaluación cuantitativa de malezas predominantes en campos de trigo y cebada de invierno en Azerbaiyán Oriental, Iran

fields, consisting of 73 winter wheat and 20 winter barley fields were studied. Field products were sampled from stem (midspring) until the end of fruition in different regions of the province. Weeds were counted and identified according to genus and species, and their stage of development was registered. The entire sample contained 136 weed species from 100 Genera, belonging to 28 families. The most frequently encountered weeds were members of the Brassicaceae, with 20 species, Poaceae, with 17 species, and Asteraceae, with 16 species. Of the 136 weed species, the majority (88%) were dicotyledonous, while the remainder was monocotyledonous. Moreover, 78% of the weeds were annual/biennial. The current study revealed predominant weed species in wheat and barley fields of East Azerbaijan province of Iran. Moreover, we demonstrated that proper weed management will substantially help to reduce the damage to wheat and barley fields. Key words: Abundance, density, weed, wheat, barley RESUMEN Con el fin de determinar la densidad y abundancia de las malezas dominantes en la provincia de Azerbaiyán Oriental de Irán, se estudiaron un total de 93 campos (73 de trigo de invierno y 20 de cebada de invierno). Los productos de campo se muestrearon desde el tallo (a mediados de primavera) hasta el final de la fructificación en diferentes regiones de la provincia. Las malezas se contaron e identificaron de acuerdo al género y la especie y se registró su estado de desarrollo. La muestra completa tuvo 136 especies de malezas de 100 géneros, pertenecientes a 28 familias. Las malezas más frecuentemente encontradas fueron los miembros de las Brassicaceae, con 20 especies, Poaceae con 17 especies y Asteraceae con 16 especies. De las 136 especies de malezas, la mayoría (88%) fueron dicotiledóneas, mientras el resto fue monocotiledóneas. Por otra parte, el 78% de las malezas fueron anuales/bianuales. El estudio reveló especies de malezas predominantes en campos de trigo y cebada de la provincia de Azerbaiyán Oriental de Irán. Además, se demostró que el manejo de malezas adecuado contribuirá sustancialmente a reducir el daño a campos de trigo y cebada. Palabras clave: Abundancia, densidad, malezas, trigo, cebad

DNA Self-Assembly of Targeted Near-Infrared-Responsive Gold Nanoparticles for Cancer Thermo-Chemotherapy

Targeted Cancer Therapy: Inspired by the ability of DNA hybridization, a targeted near-infrared (NIR) light-responsive delivery system has been developed through simple DNA self-assembly (PEG=polyethylene glycol). This DNA-based platform shows the ability of releasing therapeutics upon near-infrared irradiation, and remarkable targeted thermo- and chemotherapeutic efficacy in vitro and in vivo

Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles

PEGylated gold nanoparticles are decorated with various amounts of human transferrin (Tf) to give a series of Tf-targeted particles with near-constant size and electrokinetic potential. The effects of Tf content on nanoparticle tumor targeting were investigated in mice bearing s.c. Neuro2A tumors. Quantitative biodistributions of the nanoparticles 24 h after i.v. tail-vein injections show that the nanoparticle accumulations in the tumors and other organs are independent of Tf. However, the nanoparticle localizations within a particular organ are influenced by the Tf content. In tumor tissue, the content of targeting ligands significantly influences the number of nanoparticles localized within the cancer cells. In liver tissue, high Tf content leads to small amounts of the nanoparticles residing in hepatocytes, whereas most nanoparticles remain in nonparenchymal cells. These results suggest that targeted nanoparticles can provide greater intracellular delivery of therapeutic agents to the cancer cells within solid tumors than their nontargeted analogs

Microfluidic Platform for Combinatorial Synthesis and Optimization of Targeted Nanoparticles for Cancer Therapy

Taking a nanoparticle (NP) from discovery to clinical translation has been slow compared to small molecules, in part by the lack of systems that enable their precise engineering and rapid optimization. In this work we have developed a microfluidic platform for the rapid, combinatorial synthesis and optimization of NPs. The system takes in a number of NP precursors from which a library of NPs with varying size, surface charge, target ligand density, and drug load is produced in a reproducible manner. We rapidly synthesized 45 different formulations of poly(lactic-co-glycolic acid)-b-poly(ethylene glycol) NPs of different size and surface composition and screened and ranked the NPs for their ability to evade macrophage uptake in vitro. Comparison of the results to pharmacokinetic studies in vivo in mice revealed a correlation between in vitro screen and in vivo behavior. Next, we selected NP synthesis parameters that resulted in longer blood half-life and used the microfluidic platform to synthesize targeted NPs with varying targeting ligand density (using a model targeting ligand against cancer cells). We screened NPs in vitro against prostate cancer cells as well as macrophages, identifying one formulation that exhibited high uptake by cancer cells yet similar macrophage uptake compared to nontargeted NPs. In vivo, the selected targeted NPs showed a 3.5-fold increase in tumor accumulation in mice compared to nontargeted NPs. The developed microfluidic platform in this work represents a tool that could potentially accelerate the discovery and clinical translation of NPs.Prostate Cancer Foundation (Award in Nanotherapeutics)National Cancer Institute (U.S.) (Center of Cancer Nanotechnology Excellence at MIT-Harvard U54-CA151884National Heart, Lung, and Blood Institute (Programs of Excellence in Nanotechnology HHSN268201000045C)National Science Foundation (U.S.). Graduate Research FellowshipAmerican Society for Engineering Education. National Defense Science and Engineering Graduate FellowshipNational Cancer Institute (U.S.) (Center of Cancer Nanotechnology Excellence. Graduate Research Fellowship